RO-5508887

CAS No. 1310347-50-2

RO-5508887( RO 5508887 | RO5508887 | RG-7129 | RG7129 )

Catalog No. M11242 CAS No. 1310347-50-2

A potent, selective BACE inhibitor with IC50 of 30 nM for BACE1, equally potent against BACE2 (IC50=40 nM) .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 374 Get Quote
50MG 1935 Get Quote
100MG 2790 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    RO-5508887
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective BACE inhibitor with IC50 of 30 nM for BACE1, equally potent against BACE2 (IC50=40 nM) .
  • Description
    A potent, selective BACE inhibitor with IC50 of 30 nM for BACE1, equally potent against BACE2 (IC50=40 nM) but >1,000-fold selectivity over cathepsin D, cathepsin E, pepsin and renin; has IC50 of 18 nM in HEK293APP cells and in neuronal cultures derived from human neuronal stem cells; significantly enhances antiamyloid effect combined with gantenerumab.Alzheimer Disease Phase 1 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    RO 5508887 | RO5508887 | RG-7129 | RG7129
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    BACE
  • Recptor
    BACE
  • Research Area
    Neurological Disease
  • Indication
    Alzheimer Disease

Chemical Information

  • CAS Number
    1310347-50-2
  • Formula Weight
    389.338
  • Molecular Formula
    C18H14F3N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 85 mg/mL (218.32 mM)
  • SMILES
    CC1(C(COC(=N1)N)(F)F)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)C#N)F
  • Chemical Name
    5-Cyano-pyridine-2-carboxylic acid [3-((R)-2-amino-5,5-difluoro-4-methyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluorophenyl]amide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Jacobsen H, et al. J Neurosci. 2014 Aug 27;34(35):11621-30.
molnova catalog
related products
  • Elenbecestat (b)

    Elenbecestat (E2609)?is a novel potent, oral BACE1 inhibitor for treatment of Alzheimer's disease.

  • LY2886721

    LY2886721 is a highly potent, selective BACE1 aspartyl protease inhibitor with IC50 of 20.3 and 10.2 nM for BACE1 and BACE2.

  • Aloeresin D

    Aloeresin D a natural chromone glycoside inhibits β-Secretase (BACE1) activity (IC50: 39 μM).